PlainRecalls
FDA Devices Low Class III Ongoing

Tobra Full Dose CE Antibiotic Simplex P- Indicated for the fixation of prostheses to living bone in orthopaedic Catalog Number:6197-1-001

Reported: December 28, 2022 Initiated: November 7, 2022 #Z-0737-2023

Product Description

Tobra Full Dose CE Antibiotic Simplex P- Indicated for the fixation of prostheses to living bone in orthopaedic Catalog Number:6197-1-001

Reason for Recall

Instructions for Use (IFU) included in the packaging is missing a translation in the Turkish language. Although the Turkish translation is missing, all content within the IFUs is accurate.

Details

Recalling Firm
Howmedica Osteonics Corp.
Units Affected
20 units
Distribution
International distribution in the country of Turkey.
Location
Mahwah, NJ

Frequently Asked Questions

What product was recalled?
Tobra Full Dose CE Antibiotic Simplex P- Indicated for the fixation of prostheses to living bone in orthopaedic Catalog Number:6197-1-001. Recalled by Howmedica Osteonics Corp.. Units affected: 20 units.
Why was this product recalled?
Instructions for Use (IFU) included in the packaging is missing a translation in the Turkish language. Although the Turkish translation is missing, all content within the IFUs is accurate.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 28, 2022. Severity: Low. Recall number: Z-0737-2023.